• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
Displaying 54-68 of 1,464 results

21 Reply: PETITIONERS REPLY TO PATENT OWNERS RESPONSE TO THE PETITION

Document IPR2019-00451, No. 21 Reply - PETITIONERS REPLY TO PATENT OWNERS RESPONSE TO THE PETITION (P.T.A.B. Jan. 28, 2020)
Found on those six SIGMA catalog pages are approximately 150 different compounds divided among four discrete sub-classes: (i) anionic, (ii) cationic, (iii) zwitterionic (amphoteric) and (iv) nonionic (polar).
); see Lockwood v. Am. Airlines, Inc., 107 F.3d 1565, 1572 (Fed. Cir. 1997) (“It is not sufficient for purposes of the written description requirement of § 112 that the disclosure, when combined with the knowledge in the art, would lead one to speculate as to the modifications that the inventor might have envisioned, but failed to disclose.”).
Ex parte Maziere, 27 USPQ2d 1705 (BPAI 1993), cited by PO (POR24), is inapplicable –it was directed to foreign (not provisional) applications and is contrary to public policy reasons against incorporation-by-reference of essential material from non-patent documents.
Many benzodiazepines, including diazepam, are so slightly soluble in water that a therapeutically effective amount cannot be dissolved in a volume of aqueous solvent that is amenable to nasal insufflation as an aerosol or non-aerosol spray.” Cartt’784.Ex.1015¶[0139]-[0144](emphasis supplied).
Referring to the ‘876 Patent’s Figs. 1–3, Tables 4-1, 11-1, 11-2, and 11-3, and the same data from an EPO prosecution, the Board stated that “Petitioner’s assertion that Patent Owner never showed any unexpected results is not sufficiently supported by the evidence of record.” Decision17-21,24-27.
cite Cite Document
Analyze

No. 1

Document Celgene Corporation v. Mylan Pharmaceuticals Inc. et al, 1:20-cv-00003, No. 1 (N.D.W.Va. Jan. 3, 2020)

cite Cite Document
Analyze

18 Other Not for motions: Petitioners First Updated Mandatory Notices Update

Document IPR2019-00451, No. 18 Other Not for motions - Petitioners First Updated Mandatory Notices Update (P.T.A.B. Nov. 15, 2019)

cite Cite Document
Analyze

36 Order: Granting Petitioners Unopposed Motions for Pro Hac Vice Recognition

Document IPR2017-01528, No. 36 Order - Granting Petitioners Unopposed Motions for Pro Hac Vice Recognition (P.T.A.B. Jun. 6, 2018)

cite Cite Document
Analyze

37 Order: Granting Petitioners Unopposed Motions for Pro Hac Vice Recognition

Document IPR2017-01526, No. 37 Order - Granting Petitioners Unopposed Motions for Pro Hac Vice Recognition (P.T.A.B. Jun. 6, 2018)

cite Cite Document
Analyze

29 Order: Order Granting Patent Owners Pro Hac Vice Motions to Admit Robert Vla...

Document IPR2017-01528, No. 29 Order - Order Granting Patent Owners Pro Hac Vice Motions to Admit Robert Vlasis (P.T.A.B. May. 3, 2018)

cite Cite Document
Analyze

30 Order: Order Granting Patent Owners Pro Hac Vice Motions to Admit Robert Vla...

Document IPR2017-01526, No. 30 Order - Order Granting Patent Owners Pro Hac Vice Motions to Admit Robert Vlasis (P.T.A.B. May. 3, 2018)

cite Cite Document
Analyze

37 Exhibit List: PETITIONERS SECOND UPDATED EXHIBIT LIST

Document IPR2019-00451, No. 37 Exhibit List - PETITIONERS SECOND UPDATED EXHIBIT LIST (P.T.A.B. Apr. 28, 2020)

cite Cite Document
Analyze

40 Exhibit List: Patent Owners Updated Exhibit List

Document IPR2019-00451, No. 40 Exhibit List - Patent Owners Updated Exhibit List (P.T.A.B. Apr. 28, 2020)

cite Cite Document
Analyze

No. 168

Document Bayer HealthCare LLC et al v. Mylan Pharmaceuticals Inc., 1:15-cv-00114, No. 168 (D.Del. Mar. 14, 2018)

cite Cite Document
Analyze

97 Notice: Patent Owner Sanofi Aventis Deutschland GmbH¿¿¿s Notice of Extension...

Document IPR2017-01528, No. 97 Notice - Patent Owner Sanofi Aventis Deutschland GmbH¿¿¿s Notice of Extension of Time to File Petition for Writ of Certiorari (P.T.A.B. Apr. 15, 2020)

cite Cite Document
Analyze

99 Notice: Patent Owner Sanofi Aventis Deutschland GmbH¿¿¿s Notice of Extension...

Document IPR2017-01526, No. 99 Notice - Patent Owner Sanofi Aventis Deutschland GmbH¿¿¿s Notice of Extension of Time to File Petition for Writ of Certiorari (P.T.A.B. Apr. 15, 2020)

cite Cite Document
Analyze

22 Order: Order Granting in part and Denying in part PetitionersMotion for Supplem...

Document IPR2017-01528, No. 22 Order - Order Granting in part and Denying in part PetitionersMotion for Supplemental Information (P.T.A.B. Feb. 21, 2018)

cite Cite Document
Analyze

21 Order Conduct of Proceeding: Order Conduct of the ProceedingExtending Due ...

Document IPR2017-01528, No. 21 Order Conduct of Proceeding - Order Conduct of the ProceedingExtending Due Date 1 and Due Date 2 of the Scheduling Order (P.T.A.B. Feb. 21, 2018)

cite Cite Document
Analyze

22 Order Conduct of Proceeding: Order Conduct of the ProceedingExtending Due ...

Document IPR2017-01526, No. 22 Order Conduct of Proceeding - Order Conduct of the ProceedingExtending Due Date 1 and Due Date 2 of the Scheduling Order (P.T.A.B. Feb. 21, 2018)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 ... >>